Principal Financial Group’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
Principal Financial Group's IRMD Position: Q2 2026 in Review
Principal Financial Group increased its iRadimed (IRMD) stake by 8.9% in Q2 2026, buying an estimated $79.1K and bringing the position to 10,601 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1938.
Principal Financial Group first reported a position in IRMD in Q3 2024 and has held it in 7 quarters since. 213 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Principal Financial Group held 10,601 shares of iRadimed worth $1.01M as of Q2 2026.
- Principal Financial Group bought 869 iRadimed shares in Q2 2026, an estimated $79.1K.
- iRadimed made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1938 holding.
- Principal Financial Group first reported a position in iRadimed in Q3 2024 and has held it in 7 quarters since.
- 213 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.